MESOP : PKK CORNERED – WILL CEMIL B. & MURAT K. GO FOR A VISIT TO IMRALI ? (Cause APO is not in the position to come for a small talk to Kandil)
ORDERS FROM IMRALI : Only Ocalan can persuade PKK to lay down arms: senior PKK leader
16 Mar 2015 – Abdullah Ocalan, the jailed leader of the outlawed Kurdistan Workers’ Party (PKK), is the only person who can persuade the militants to lay down their arms, a senior PKK leader in the Qandil Mountains said.
“The only person who can persuade [the militants] to lay down arms is leader Apo [Ocalan],” Cemil Bayik, co-chair of the Kurdistan Communities Union (KCK), a supra organization that includes the PKK, said in an interview with daily Cumhuriyet published on March 15. He also said Ocalan, who is serving a life-sentence on Imrali Island, must be released and allowed to meet with the PKK militants in person.
“Nobody can persuade the guerilla but leader Apo. We are holding the co-leadership of this organization but even we cannot persuade the guerilla. The only person who can persuade them is leader Apo. If [Ocalan] meets the guerilla leaders [in person] then it is possible to persuade them,” Bayik said. Bayik also said they have to meet with Ocalan face-to-face and added they can visit him on Imrali Island but they wished for his release, Hurriyet daily said. He insisted Ocalan should be released and allowed to speak with the PKK in person, adding that demanding the release of Ocalan as part of the peace process is a “realistic demand.” Bayik also said the PKK has taken all steps it has to take so far as part of the process and now it’s the government’s turn to take steps. He said the Turkish government has not accepted their demands for the involvement of a third party during the meetings in the past. He accused the government of denying the existence of a Kurdish problem. “The state and the government do not accept the Kurdish problem, and the Kurdish people. They accept the problem as a terror problem rather than a Kurdish problem. But this thesis has broken down,” he claimed.